Literature DB >> 11780692

Carboxyhemoglobin levels in patients with sickle-cell anemia: relationship to hemolytic and vasoocclusive severity.

D A Sears1, M M Udden, L J Thomas.   

Abstract

BACKGROUND: When carbon monoxide binds to hemoglobin, it increases the affinity of hemoglobin for oxygen and shifts the oxygen dissociation curve to the left. The resulting decrease in sickling tendency could have clinical benefit, and carbon monoxide has been suggested as a treatment for sickle-cell disease. Furthermore, in sickle-cell disease, as in other hemolytic diseases, endogenous carbon monoxide production is increased because of increased heme catabolism.
METHODS: In the present study, we measured carboxyhemoglobin levels in sickle-cell patients and compared them with estimates of the hemolytic and the vasoocclusive severity of the disease.
RESULTS: Significant correlation was found between carboxyhemoglobin (HbCO) levels and hematocrit, reticulocyte count, unconjugated bilirubin level, and percentage of irreversibly sickled cells. However, there was no significant correlation between carboxyhemoglobin levels and measures of the vaso-occlusive severity of the disease.
CONCLUSIONS: The correlations between HbCO levels and measures of hemolytic severity are best explained by the known relationship between hemoglobin catabolism and CO production. The lack of correlation with vaso-occlusive severity may be due to the complex changes involved and the difficulty of quantifying vasoocclusive severity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11780692     DOI: 10.1097/00000441-200112000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  9 in total

1.  Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1.

Authors:  Ceri Evans; Katharine Orf; Erzsebet Horvath; Michael Levin; Josu De La Fuente; Subarna Chakravorty; Aubrey J Cunnington
Journal:  Haematologica       Date:  2015-08-27       Impact factor: 9.941

Review 2.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

3.  Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.

Authors:  Ashutosh Lal; Lasandra Patterson; Alisa Goldrich; Anne Marsh
Journal:  Pediatr Blood Cancer       Date:  2015-02-14       Impact factor: 3.167

4.  Non-invasive measurements of carboxyhemoglobin and methemoglobin in children with sickle cell disease.

Authors:  Jason B Caboot; Abbas F Jawad; Joseph M McDonough; Cheryl Y Bowdre; Raanan Arens; Carole L Marcus; Thornton B A Mason; Kim Smith-Whitley; Kwaku Ohene-Frempong; Julian L Allen
Journal:  Pediatr Pulmonol       Date:  2012-02-10

Review 5.  "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.

Authors:  Xiaoxiao Yang; Wen Lu; Minjia Wang; Chalet Tan; Binghe Wang
Journal:  J Control Release       Date:  2021-09-02       Impact factor: 11.467

6.  Endogenous carbon monoxide production in extracorporeal membrane oxygenation-related hemolysis: potential use of point-of-care CO-oximetry carboxyhemoglobin to detect hemolysis.

Authors:  Chan Kai Man; Lam Koon Ngai
Journal:  Clin Case Rep       Date:  2018-01-03

Review 7.  A review of the experimental evidence on the toxicokinetics of carbon monoxide: the potential role of pathophysiology among susceptible groups.

Authors:  Prabjit Barn; Luisa Giles; Marie-Eve Héroux; Tom Kosatsky
Journal:  Environ Health       Date:  2018-02-05       Impact factor: 5.984

8.  Carboxyhemoglobin (CO-Hb) Correlates with Hemolysis and Hospital Mortality in Extracorporeal Membrane Oxygenation: A Retrospective Registry.

Authors:  Xavier Bemtgen; Jonathan Rilinger; Manuel Holst; Felix Rottmann; Corinna N Lang; Markus Jäckel; Viviane Zotzmann; Christoph Benk; Tobias Wengenmayer; Alexander Supady; Dawid L Staudacher
Journal:  Diagnostics (Basel)       Date:  2022-07-05

9.  Methaemoglobin and COHb in patients with malaria.

Authors:  Thomas Hänscheid; Tom Gresnigt; Sascha Löhr; Arnaud Flamen; Thomas Zoller; José Melo-Cristino; Martin P Grobusch
Journal:  Malar J       Date:  2014-07-23       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.